David Morens
David M. Morens | |
---|---|
Born | 1947 (age 77–78) United States |
Nationality | American |
Alma mater | University of Michigan (A.B. 1969; M.D. 1973)[1] |
Known for | Research on emerging infectious diseases; historical epidemiology of influenza, dengue & Lassa fever |
Awards | U.S. Public Health Service Meritorious & Outstanding Service Medals; DHHS Distinguished Service Award[1] |
Scientific career | |
Fields | Virology; Epidemiology; Infectious diseases |
Institutions | Centers for Disease Control and Prevention (1976–1982)[2]
|
David M. Morens is an American physician-scientist, medical historian and Senior Advisor to the Director of the National Institute of Allergy and Infectious Diseases (NIAID).[1] A career officer in the United States Public Health Service, he has investigated outbreaks from Ebola and Lassa fever to COVID-19 and publishes widely on viral pathogenesis and the history of pandemics.[3][2][4]
Early life and education
[edit]Morens earned an A.B. in psychology (1969) and an M.D. (1973) from the University of Michigan.[1] He completed pediatrics residency at the UCSF School of Medicine and fellowship training in pediatric infectious diseases, becoming board-certified in Pediatrics (1978) and Preventive Medicine (1980).[2]
Career
[edit]Centers for Disease Control and Prevention (1976 – 1982)
[edit]Commissioned into the Epidemic Intelligence Service, Morens set up national surveillance for Reye syndrome and Kawasaki disease and co-discovered the Snow Mountain strain of norovirus.[2] Stationed in Sierra Leone from 1979 to 1981, he ran clinical trials of ribavirin for Lassa fever and led epidemiologic field studies.[1] He later headed CDC’s Respiratory & Special Pathogens Branch and directed the laboratory arm of the agency’s first national AIDS case-control study.[2]
University of Hawaiʻi (1982 – 1998)
[edit]At the University of Hawaiʻi, Morens was Professor of Tropical Medicine, Chair of Epidemiology, and laboratory director of dengue-virus projects funded by WHO and NIH. His group developed a BHK-21 neutralization assay still used for flaviviruses.[5] During this period he also published historical analyses of epidemics ranging from the Plague of Athens to 20th-century influenza.[6]
NIAID (1998 – present)
[edit]Since 1998 Morens has advised successive NIAID directors on emerging-disease policy and pandemic preparedness.[3] He co-authored influential papers advocating universal coronavirus vaccines[7] and continues research on viral host-switching and disease pathogenesis in NIAID’s Viral Pathogenesis and Evolution Laboratory.[1]
Selected works
[edit]- Morens, D.M.; Fauci, A.S. (2007). "The 1918 influenza pandemic: insights for the 21st century". Journal of Infectious Diseases. 195 (7): 1018–1028. doi:10.1086/511989. PMID 17330793.
- Morens, D.M.; Taubenberger, J.K. (2006). "1918 Influenza: the mother of all pandemics". Emerging Infectious Diseases. 12 (1): 15–22. PMC 3291398. PMID 16494711.
- McCormick, J.B.; Morens, D.M. (1986). "Clinical observations and virologic studies of patients with Lassa fever treated with ribavirin". Journal of Infectious Diseases. 155 (3): 445–455. doi:10.1093/infdis/155.3.445. PMID 4026390.
Professional service and honors
[edit]- President, American Epidemiological Society (2008–2009)[8]
- Chair, American Committee on Arthropod-Borne & Zoonotic Viruses (1999–2001)[9]
- Fellow, Infectious Diseases Society of America and American Society of Tropical Medicine and Hygiene[10]
- Recipient, U.S. Public Health Service Meritorious & Outstanding Service Medals; DHHS Distinguished Service Award[1]
References
[edit]- ^ a b c d e f g h "David M. Morens, M.D. – Senior Advisor to the NIAID Director" (PDF). US Congress. Retrieved 28 April 2025.
- ^ a b c d e "Editors – *Emerging Infectious Diseases*" (PDF). US Congress. Retrieved 28 April 2025.
- ^ a b "NIH scientist: "It's time to get really serious" about a universal COVID vaccine". Government Executive. 15 December 2021. Retrieved 28 April 2025.
- ^ "Editors – *Emerging Infectious Diseases*" (PDF). US Congress. Retrieved 28 April 2025.
- ^ Morens, D.M.; Halstead, S.B. (1990). "Measurement of dengue neutralizing antibody levels in humans using a BHK-21 assay". Journal of Clinical Microbiology. 28 (1): 107–113. PMC 269568. PMID 2156879.
- ^ Morens, D.M.; Littman, R.J. (1992). "Epidemiology of the Plague of Athens". Transactions of the American Philological Association. 122: 271–304. doi:10.2307/284374.
- ^ Morens, D.M.; Taubenberger, J.K.; Fauci, A.S. (2022). "Universal coronavirus vaccines — an urgent need". New England Journal of Medicine. 386 (4): 297–299. doi:10.1056/NEJMp2118468. PMC 11000439. PMID 34915735.
- ^ "Past Presidents – American Epidemiological Society". American Epidemiological Society. Retrieved 28 April 2025.
- ^ "Past Chairs – American Committee on Arthropod-Borne & Zoonotic Viruses". American Society of Tropical Medicine & Hygiene. Retrieved 28 April 2025.
- ^ "David M. Morens, MD – ReachMD Contributor Profile". ReachMD. Retrieved 28 April 2025.